Ain Shams University Hospitals
Cairo, Cairo Governorate, 11511, Egypt
NCT Number: NCT07320833
This randomized, double-blind comparative study evaluates postoperative analgesic efficacy and motor effects of ultrasound-guided para-sartorial compartments (PASC) block versus ultrasound-guided combined femoral-sciatic nerve block in patients undergoing total knee arthroplasty. The primary endpoint is total nalbuphine rescue analgesia consumption in the first 24 postoperative hours. Secondary endpoints include pain scores (NRS), motor function using a modified Bromage scale, block performance characteristics, and complications.
Looking for future studies?
Notify Me60 year–70 year
All sexes
Interventional
Not applicable
Cairo, Cairo Governorate, 11511, Egypt
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Single-shot ultrasound-guided femoral nerve block (15 milliliters of 0.25% bupivacaine) plus single-shot ultrasound-guided popliteal sciatic nerve block (15 milliliters of 0.25% bupivacaine), performed after induction of general anesthesia using sterile technique.
Single-shot ultrasound-guided para-sartorial compartments block performed after induction of general anesthesia using a single needle entry point and three injections of 0.25% bupivacaine: 10 milliliters in the femoral triangle with periarterial and subsartorial spread, 10 milliliters in the subsartorial plane at the apex of the femoral triangle, and 10 milliliters in the suprasartorial compartment at the level of the intermediate femoral cutaneous nerve (total 30 milliliters).
Time frame: First 24 hours after surgery.
Total dose of intravenous nalbuphine (in milligrams) administered as rescue analgesia when the Numeric Rating Scale pain score is 3 or higher, with a maximum daily dose of 20 milligrams.
Time frame: 30 minutes after admission to the post-anesthesia care unit, and 3 hours, 6 hours, 12 hours, and 24 hours after surgery.
Pain intensity measured using the Numeric Rating Scale (0 = no pain, 10 = worst possible pain).
Time frame: 2 hours, 4 hours, 6 hours, 12 hours, 18 hours, and 24 hours after surgery.
Motor function assessed using the modified Bromage scale: 1 = complete block (unable to move knee or feet), 2 = almost complete (able to move feet only), 3 = partial (just able to move knees), 4 = none (full flexion of knees and feet).
Time frame: During block performance immediately after induction of general anesthesia.
Time from ultrasound scanning start to completion of local anesthetic injection (in minutes).
Time frame: Up to 24 hours after surgery.
Duration of sensory and motor effects of the nerve block as assessed clinically (in hours).
Time frame: First 24 hours after surgery.
Presence of postoperative nausea during the first postoperative day.
Time frame: First 24 hours after surgery.
Presence of postoperative vomiting during the first postoperative day.
Time frame: First 24 hours after surgery.
Richmond Agitation-Sedation Scale score ranging from +4 (combative) to -5 (unarousable); 0 indicates alert and calm.
Ain Shams University
Other
Postoperative Analgesic Efficacy of Ultrasound Guided Para-sartorial Compartments (PASC) Block Versus Combined Femoral-Sciatic Nerve Block in Patients Undergoing Total Knee Arthroplasty: A Double-Blind Randomized Comparative Study
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07506629
Adductor Canal Block, Arthritis
View Trial DetailsNCT07134283
Arthritis, Cryotherapy
Ankara, Turkey (Türkiye)
View Trial DetailsNCT05974501
Arthritis, Arthroplasty Complications
Miami, Florida, United States
View Trial DetailsNCT03698006
Arthritis, Joint Diseases
Lausanne, English, Switzerland
View Trial Details